Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

Source:http://linkedlifedata.com/resource/pubmed/id/17586305

Lancet 2007 Jun 23 369 9579 2097-105

Download in:

View as

General Info

PMID
17586305